Back to Search
Start Over
Chemoenzymatic synthesis and biological evaluation of ganglioside GM3 and lyso-GM3 as potential agents for cancer therapy.
- Source :
-
Carbohydrate research [Carbohydr Res] 2021 Nov; Vol. 509, pp. 108431. Date of Electronic Publication: 2021 Sep 03. - Publication Year :
- 2021
-
Abstract
- A highly efficient chemoenzymatic method for synthesizing ganglioside GM3 and lyso-GM3 was reported here. Enzymatic extension of the chemically synthesized lactosyl sphingosine using efficient one-pot multienzyme (OPME) reaction allowed glycosylation to be carried out in aqueous solutions realizing the greening of reactions. Ganglioside GM3 was synthesized through 10 steps with a total yield of 22%. Lyso-GM3 was very useful for kinds of derivatization. The anti-proliferation activity studies demonstrated that these compounds 14-16 with sphingosine exhibited more potency than the corresponding lyso-GM3 with ceramide. All ganglioside GM3 and lyso-GM3 can effectively inhibit the migration of melanoma B16-F10 cells. These chemoenzymaticlly synthesized GM3 and lyso-GM3 exhibited antitumor activities, which can provide valuable sights to search new antitumor agents for cancer therapy.<br /> (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Subjects :
- Animals
Mice
Cell Line, Tumor
Cell Movement drug effects
Humans
Drug Screening Assays, Antitumor
G(M3) Ganglioside chemistry
G(M3) Ganglioside chemical synthesis
Antineoplastic Agents pharmacology
Antineoplastic Agents chemical synthesis
Antineoplastic Agents chemistry
Cell Proliferation drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1873-426X
- Volume :
- 509
- Database :
- MEDLINE
- Journal :
- Carbohydrate research
- Publication Type :
- Academic Journal
- Accession number :
- 34492428
- Full Text :
- https://doi.org/10.1016/j.carres.2021.108431